How Much Does Enbrel Cost?

Our most recent US pharmacy data shows a low of roughly $7,709.52 for Enbrel with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.

We found Canadian pricing for Enbrel starting near $623.75 per tablet in USD terms. That's before any shipping charge, which the table above breaks out separately.

Drug pricing is set separately in each country through different negotiation, regulatory, and distribution systems, so the same medication can legitimately carry different price tags on either side of the border. Check the comparison table above for the specific numbers on Enbrel.

Generic and brand-name pricing for Enbrel is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.

The final cost of Enbrel with insurance depends on your specific plan's formulary, copayment, coinsurance rates, and deductible status. While insurance often provides substantial coverage, patients may still have significant out-of-pocket expenses. It's advisable to contact your insurance provider directly for precise cost details. In some cases, comparing your insurance copay against prices available through pharmacy savings programs may be beneficial.

Medicare coverage for Enbrel is not uniform and depends on the specific Part D or Medicare Advantage plan, its formulary, and the beneficiary's coverage phase (e.g., deductible, initial coverage, or coverage gap). To understand your potential copay or coinsurance, you should review your plan's drug list. For situations where Medicare coverage is limited or unavailable, exploring other savings options like manufacturer patient assistance programs may help reduce costs.

No, a generic version of Enbrel is not currently on the market. Enbrel is a brand-name biologic drug whose patent protections are expected to last until around 2029. After this date, biosimilar versions—which are similar but not identical to the original biologic—may become available.